Biotronik Says CoStar Stent 'Recall' Violated Pact

By Eric Hornbeck (July 12, 2011, 6:19 PM EDT) -- Biotronik AG told a New York state judge Tuesday that Conor Medsystems Inc. reneged on a supply contract when it stopped providing CoStar stents to the German biopharmaceutical company and then painted the breach as a recall.

Conor — a Johnson & Johnson unit — pulled its CoStar stents off the market in 2007, a move that allegedly cost Biotronik over $100 million, according to court documents.

"They said they'd supply the stents, and they didn't," Biotronik attorney Ronald S. Rauchberg of Proskauer Rose LLP told New York Supreme Court Judge Bernard Fried on Tuesday.

"It couldn't be simpler or clearer,"...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!